Microport Scientific (853.HK) Osake Kurssi
Microport Scientific Kurssi
Liikevaihto on kasvanut 18,8 % vuodessa viimeisten 17 vuoden aikana 1,03 Mrd. USD:een. Osakekohtainen tulos on kasvanut 7,3 % vuodessa viimeisten 12 vuoden aikana. Microport Scientificn nettomarginaali on nyt −20,8 %, noussut −29,5 %:sta muutama vuosi sitten. Microport Scientificn osinkotuotto on tällä hetkellä noin 5,55 %. Analyytikoiden mediaanitavoitehinta on 2,08 USD, eli yli nykyhintaa 168,7 %. 10 analyytikosta 7 suosittaa ostoa — kokonaiskonsensus on Osta.
Microport Scientific osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Microport Scientific liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Microport Scientific -osakkeesta
The business model of Microport Scientific Corp. is centered around the research, development, and sale of high-quality medical devices. With a focus on improving healthcare outcomes, the company specializes in products for cardiovascular, orthopedic, and other medical specialties. Microport Scientific Corp. operates both domestically and internationally, catering to the needs of medical professionals and patients worldwide. By leveraging advanced technologies and innovative solutions, Microport aims to provide superior medical devices and therapies that enhance patient well-being. The company's commitment to excellence and continuous improvement has made it a prominent player in the global medical device industry.
Microport Scientific Corp is primarily active in the medical device industry.
The main competitors of Microport Scientific Corp in the market include companies such as Medtronic, Abbott Laboratories, Boston Scientific Corporation, and Johnson & Johnson. These companies operate in the medical device industry and offer similar products and solutions. Microport Scientific Corp competes with them in areas such as cardiac rhythm management, orthopedics, neurovascular, and endovascular businesses. These competitors play a significant role in shaping the competitive landscape for Microport Scientific Corp and drive innovation and advancements in the industry.
Microport Scientific Corp is a renowned medical device manufacturer based in Shanghai, China. Founded in 1998, the company has grown to become a leading player in the global cardiovascular industry. Microport specializes in the development, production, and distribution of innovative medical devices, including stents, artificial joints, electrophysiology devices, and more. With a strong emphasis on research and development, Microport strives to improve patient outcomes and enhance healthcare practices worldwide. Today, Microport Scientific Corp stands as a trusted brand in the medical field, committed to advancing medical technology and delivering high-quality products to healthcare providers and patients globally.
Some significant milestones that Microport Scientific Corp has achieved include successfully developing innovative medical technologies and gaining regulatory approvals for their products. The company has achieved milestones in the field of interventional cardiology and orthopedics, providing solutions for the treatment of cardiovascular diseases and joint disorders. Microport has also established strategic collaborations and expanded its global presence through acquisitions and partnerships. These accomplishments have strengthened Microport's position in the medical device industry and allowed them to continue delivering advanced healthcare solutions to patients worldwide.
Microport Scientific Corp is primarily present in several countries and regions, including the United States, China, Europe, and Asia-Pacific. With a global reach, Microport Scientific Corp has established its presence in key markets around the world. This enables the company to effectively serve its customers and expand its business operations.
Microport Scientific Corp is committed to delivering value-driven solutions and has a robust corporate philosophy. The company prioritizes innovation, aiming to provide cutting-edge medical devices and technology that enhance patient care. Microport focuses on creating medical solutions that are safe, effective, and accessible to a wide range of patients worldwide. Their commitment to quality and excellence is demonstrated through their stringent quality control processes and continuous improvement initiatives. With a customer-centric approach, Microport aims to meet the evolving needs of healthcare professionals and improve global healthcare outcomes. As a recognized industry leader, Microport Scientific Corp continues to drive advancements and make a positive impact in the medical field.
Analyytikot asettavat tällä hetkellä Microport Scientific-osakkeelle keskimääräisen tavoitehinnan 1,95 USD (mediaani: 2,08 USD), mikä merkitsee +151,2 % viimeisimpään hintaan verrattuna. Konsensus perustuu 10 analyytikkoarvioon.
10 analyytikkoa arvioi tällä hetkellä Microport Scientific-osaketta: 7 suosittaa ostoa, 3 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Microport Scientific-yhtiöltä 1,29 Mrd. USD liikevaihtoa ja 0,03 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Microport Scientific-osake noteerataan hintaan 0,69 EUR (0,77 USD).
Microport Scientific-osake (853.HK) on listattuna 3 pörssissä, muun muassa: Hongkong (HKEX) (0853.HK), Frankfurt (MSK.F).
Microport Scientific Corp is a leading medical technology company based in Shanghai, China. The company focuses on the development and manufacturing of medical devices and implantable medical aids. The core business of Microport Scientific Corp currently includes three major divisions: cardiology, orthopedics, and endovascular therapy. These divisions are specifically designed to offer products and services to hospitals and clinics worldwide that help patients and support medical personnel in diagnosis and treatment. In the cardiology division, Microport Scientific Corp offers a wide range of products, including coronary stents, balloon dilators, heart valves, and electrophysiology products. These products assist in the treatment of cardiovascular diseases such as heart attack, angina, or arrhythmia. In the orthopedics field, the company focuses on the production of hip, knee, and shoulder endoprostheses, as well as trauma implants. These implants provide a solution for patients suffering from joint diseases or injuries. Additionally, Microport Scientific Corp also manufactures spinal implants that can assist in the treatment of back pain. The company's third division, endovascular therapy, focuses on the production of devices used in blood vessels. These products can be used in the treatment of aortic aneurysms and peripheral arterial diseases. In addition to these three main divisions, Microport Scientific Corp also produces products for other medical areas, such as pressure measurement and pulmonology. The business model of Microport Scientific Corp is to develop, manufacture, and distribute medical devices and implantable medical aids worldwide. The focus is on solving medical problems that are difficult or impossible for patients to solve. The company works closely with medical professionals to ensure that the products and services provided truly meet the needs of patients and medical personnel. Continuous investment in research and development is made to develop more innovative and effective medical devices. Furthermore, the company collaborates closely with hospitals and clinics to ensure that they receive the necessary products and services and that optimal patient care is provided. Overall, Microport Scientific Corp is a successful medical technology company that specializes in the development and manufacturing of medical devices and implantable medical aids. Through close collaboration with medical professionals and hospitals, the company is able to offer products and services that meet the needs of patients and also support medical personnel in diagnosis and treatment.
odotettu liikevaihto Microport Scientific on 1,29 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Microport Scientific on 57,67 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Microport Scientific:n hinta-voitto-suhde (P/E) on tällä hetkellä 24,60. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Microport Scientific-osakkeen arvostusta.
Microport Scientific:n hinta-myynti-suhde (P/S) on tällä hetkellä 1,10. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Microport Scientific-osakkeen arvostuskennuslukuna.
Microport Scientific:n Eulpool-laatuscore on 3/10.
Microport Scientific:n ISIN on KYG608371046. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Microport Scientific:n WKN on A1C5AB. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Microport Scientific:n ticker on 853.HK. Tämä pörssinoteeraus käytetään Microport Scientific-osakkeiden kauppaan pörssissä.
Microport Scientific osake
Microport Scientific vertaisryhmä
Microport Scientific Ticker
Microport Scientific FIGI
Kaikki tunnusluvut ja syvällinen analyysi Microport Scientific:sta
Meidän osakeanalyysimme Microport Scientific-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Microport Scientific:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: